Concepedia

Botai Li

BL

Statistics

Publications

9

Citations

2K

H-Index

9

Active since

2018

Affiliations

Shanghai Cancer Institute(Current)

Renji Hospital

Shanghai Jiao Tong University

State Key Laboratory of Oncogene and Related Genes

Fudan University

Botai Li is an author at Shanghai Cancer Institute specializing in molecular oncology, oncology, and medicine.

Publications per year

2018–2024

9

Publications

9

circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity

Botai Li, Lili Zhu, Chunlai Lu et al. · Nature Communications · 2021 · 860 citations · Full text

, , +17

circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1

Zhuoan Cheng, Chengtao Yu, Shaohua Cui et al. · Nature Communications · 2019 · 528 citations · Full text

, , +17

Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-κB pathway in hepatocellular carcinoma

Hui Wang, Linhui Liang, Qiongzhu Dong et al. · Theranostics · 2018 · 196 citations · Full text

, , +17

PPARγ Coactivator‐1α Suppresses Metastasis of Hepatocellular Carcinoma by Inhibiting Warburg Effect by PPARγ–Dependent WNT/β‐Catenin/Pyruvate Dehydrogenase Kinase Isozyme 1 Axis

Qiaozhu Zuo, Jia He, Shu Zhang et al. · Hepatology · 2020 · 182 citations

, , +17

circFOXM1 promotes proliferation of non-small cell lung carcinoma cells by acting as a ceRNA to upregulate FAM83D

Chengtao Yu, Zhuoan Cheng, Shaohua Cui et al. · Journal of Experimental & Clinical Cancer Research · 2020 · 72 citations · Full text

, , +17

1–5 of 9